ACHILLES THERAPEUTICS
Achilles Therapeutics is a developer of immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer. The company's immunotherapies harness the immune system to destroy cancer cells that target truncal tumor neo-antigens and flags to the immune system present on the surface of every cancer cell, enabling scientists to target and destroy tumors without harming healthy tissues.
ACHILLES THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics Wellness
Founded:
2016-05-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.achillestx.com
Total Employee:
1+
Status:
Active
Contact:
+44 (0)1438 906 906
Email Addresses:
[email protected]
Total Funding:
212.99 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Content Delivery Network Nginx Microsoft Exchange Online Amazon Office 365 Mail
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Bactolife
Bactolife helps in developing innovative solutions meeting the global need for reducing antimicrobial resistance.
Blueheart
Blueheart is the emerging category leader for digital therapeutics (DTx) for relationship strength.
Carrick Therapeutics
Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.
Engimmune Therapeutics
Engimmune Therapeutics is a platform and product development company engineering next-generation T cell receptor therapies.
Evolva
Evolva develops sustainably produced natural flavors, sweeteners and functional ingredients for food, beverage and healthcare products.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
IDUN Technologies
IDUN Technologies is developing the Internet of Humans, a world where devices and apps react to your emotional needs.
Inceptor Bio
Inceptor Bio develops cell therapy solutions to cure difficult-to-treat cancers.
Myovant Sciences
Myovant Sciences is to deliver innovative women's health and prostate cancer solutions by efficiently advancing new medicines to market.
NapiFeryn BioTech
NapiFeryn BioTech is a patent holder on a technology of producing protein isolates from oil plant seed, particularly from rapeseed.
Ori Biotech
Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments.
Pandion Therapeutics
Pandion Therapeutics develops innovative modular proteins, antibodies, and bispecifics for autoimmune and inflammatory diseases.
Peppy Health
Peppy is leading digital platform that helps employers give their people expert support for under-served areas of healthcare.
Peptomyc
Peptomyc focuses on the development of a new generation of cell-penetrating peptides targeting the Myconcoprotein for cancer treatment.
Perci Health
Perci Health provides holistic care, telehealth, and wellness treatment for cancer diseases.
Pipeline Therapeutics
Pipeline Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
Pneumagen
Pneumagen develops glycan targeted carbohydrate binding modules (CBMs) for respiratory tract infections ) and cancer.
PolyProx
PolyProx Therapeutics is a developer of a novel class of drug intended to provide new therapies for cancer treatment.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
T-knife
T-knife is a developer of T cell receptors intended for T cell therapy of cancer.
Tenaya Therapeutics
Tenaya Therapeutics is a developer of novel therapies designed to offer treatment for heart disease.
Current Employees Featured
Founder
Stock Details
Investors List
Horizon Capital
Horizon Capital investment in Grant - Achilles Therapeutics
Horizon 2020
Horizon 2020 investment in Grant - Achilles Therapeutics
RA Capital Management
RA Capital Management investment in Series C - Achilles Therapeutics
Redmile Group
Redmile Group investment in Series C - Achilles Therapeutics
Invus
Invus investment in Series C - Achilles Therapeutics
Boxer Capital
Boxer Capital investment in Series C - Achilles Therapeutics
OrbiMed
OrbiMed investment in Series C - Achilles Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Series C - Achilles Therapeutics
Forbion Capital Partners
Forbion Capital Partners investment in Series C - Achilles Therapeutics
Syncona Partners LLP
Syncona Partners LLP investment in Series C - Achilles Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-30 | Achilles Therapeutics Appoints James Taylor as Chief Business Officer and Cassian Yee, MD to Scientific Advisory Board |
Official Site Inspections
http://www.achillestx.com Semrush global rank: 4.37 M Semrush visits lastest month: 2.57 K
- Host name: 4.234.1.245
- IP address: 4.234.1.245
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
